1yt9
From Proteopedia
Line 1: | Line 1: | ||
[[Image:1yt9.jpg|left|200px]] | [[Image:1yt9.jpg|left|200px]] | ||
- | + | <!-- | |
- | + | The line below this paragraph, containing "STRUCTURE_1yt9", creates the "Structure Box" on the page. | |
- | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
- | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
- | | | + | or leave the SCENE parameter empty for the default display. |
- | | | + | --> |
- | + | {{STRUCTURE_1yt9| PDB=1yt9 | SCENE= }} | |
- | + | ||
- | + | ||
- | }} | + | |
'''HIV Protease with oximinoarylsulfonamide bound''' | '''HIV Protease with oximinoarylsulfonamide bound''' | ||
Line 34: | Line 31: | ||
[[Category: Yeung, C M.]] | [[Category: Yeung, C M.]] | ||
[[Category: Zhao, C.]] | [[Category: Zhao, C.]] | ||
- | [[Category: | + | [[Category: Hiv protease]] |
- | [[Category: | + | [[Category: Oximinoarylsulfonamide]] |
- | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 16:45:37 2008'' | |
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + |
Revision as of 13:45, 3 May 2008
HIV Protease with oximinoarylsulfonamide bound
Overview
The need for a potent HIV protease inhibitor (PI) to combat emerging PI-resistant viruses is anticipated. Analogs formulated from the combination of structural fragments of Ritonavir, Lopinavir, and Amprenavir were synthesized. Analogs containing the oxime pharmacophore were found to have improved activities against both wild type and resistant (A17) viruses. The synthesis and structure-activity relationships (SAR) based upon the in vitro IC50 of this series of compounds are reported.
About this Structure
1YT9 is a Single protein structure of sequence from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.
Reference
Oximinoarylsulfonamides as potent HIV protease inhibitors., Yeung CM, Klein LL, Flentge CA, Randolph JT, Zhao C, Sun M, Dekhtyar T, Stoll VS, Kempf DJ, Bioorg Med Chem Lett. 2005 May 2;15(9):2275-8. PMID:15837308 Page seeded by OCA on Sat May 3 16:45:37 2008